In 2023, Australia's Therapeutic Goods Administration (TGA) became the first regulatory body globally to allow authorized psychiatrists to prescribe MDMA for PTSD and psilocybin for treatment-resistant depression. This controversial move sparked massive global interest, blending cutting-edge neuroplasticity science with counterculture legacy. Known colloquially as 'shrooms' or 'ecstasy,' these drugs are administered alongside intense psychotherapy, costing upwards of $20,000 per patient. Proponents support this because it offers a rare, scientifically backed silver…
Read moreResponse rates from 271 Australia voters.
Trend of support over time for each answer from 271 Australia voters.
Loading data...
Loading chart...
Trend of how important this issue is for 271 Australia voters.
Loading data...
Loading chart...
Unique answers from Australia voters whose views went beyond the provided options.
@BD2FTK62mos2MO
Join in on the most popular conversations.
Based on 271 responses to this question.
These results come from iSideWith's ongoing political issues survey. We collect over a million responses per day, filter out duplicate and multiple submissions, and break the results down by political party, ideology, age, state, and census demographics (income, race, education, household).
iSideWith is non-partisan — we don't advocate for any party, candidate, or position. We report what the public tells us.
Writing about this issue? Use the live data and link back to the full results.
